In this video collection, authors of findings published in JCI Insight present personally guided tours of their results. The journal accepts video submissions from authors of recently accepted manuscripts. Instructions can be found on the Author's Take Guidelines page.
Maternal diet has profound, long-lasting effects on offspring. For example, maternal malnutrition results in fetal exposure to excessive glucocorticoid, which can result in metabolic reprogramming and hypertension. In this episode, Toshiro Fujita and colleagues exposed pregnant rodents to a low-protein diet or to the synthetic glucocorticoid dexamethasone and demonstrated that the offspring of these dams were prone to salt-sensitive hypertension. In utero glucocorticoid exposure resulted in aberrant DNA methylation of hypothalamic angiotensin receptor type 1a, resulting in increased expression. Moreover, mice lacking the DNA methyltransferase 3a became hypertensive in the absence of glucocorticoid exposure, while animals lacking the angiotensin receptor were protected from prenatal glucocorticoid exposure-induced hypertension. Together, these results reveal epigenetic modulation of angiotensin signaling underlies development of hypertension that results from prenatal exposure to glucocorticoids.
Type 1 diabetes (T1D) is an autoimmune disease characterized by an inability to produce insulin as the result of insulin-secreting pancreatic β cell loss. Neutrophils are key mediators of several autoimmune disorders; however, the contribution of these cells to T1D etiology is poorly defined. In this episode, Manuela Battaglia and colleagues discuss their work, which identifies an abnormal neutrophil signature that is present in the blood and pancreas of individuals with T1D and those that are at risk of disease. Cumulatively, these results suggest that neutrophils should be explored as a therapeutic target for T1D.
Maternal obesity has been associated with adverse outcomes in offspring; however, it is not clear how maternal obesity or high-fat diet (HFD) impart long-term effects on offspring. In this episode, Julie Mirpuri and colleagues use murine models to evaluate the effects of HFD during pregnancy on offspring. The offspring of HFD-fed mothers developed a microbiome that was distinctly different than that of offspring of mothers on a regular diet. Moreover, IL-17–producing type 3 innate lymphoid cells (ILC3s) were increased the offspring of HFD-fed mothers, a phenotype linked to the HFD-associated microbiota. The offspring of HFD-fed mothers were also more susceptible to necrotizing enterocolitis. Together, these results indicate that maternal HFD influences the offspring microbiome, thereby increasing ILC3s and susceptibility to inflammatory insult.
The proinflammatory adipokine lipocalin-2 is upregulated in obese individuals and is thought to drive renal injuries; however, the source of lipocalin-2 during kidney dysfunction is not fully understood. In this episode, Wai Yan Sun, Bo Bai, and colleagues used multiple murine models of chronic and acute kidney injury to evaluate the role of lipocalin-2. Adipose-tissue-specific deletion, but not whole-body or kidney-specific deletion, of lipocalin-2 protected mice from aldosterone- and high salt after uninephrectomy-induced kidney damage. Moreover, transplantation of WT fat pads into animals with lipocalin-2 deficient adipose tissue restored sensitivity to renal damage, and mice chronically exposed to a stable variant of human lipocalin-2 developed renal injury. Together, these results identify adipose-generated lipocalin-2 as a driver of acute and chronic kidney dysfunction.
Adult polyglucosan body disease (APBD) is a glycogen storage disorder characterized by the accumulation of polyglucosan bodies in muscle, nerve, and other tissue as the result of mutations in glycogen branching enzyme 1 (GBE1). APBD is characterized by adult-onset neurodegeneration, and recent evidence suggests that reduction of glucose 6-phosphate–stimulated glycogen synthase (GYS) activity may be beneficial. In this episode, Or Kakhlon and colleagues screened FDA-approved compounds for those able to reduce GYS activity and polyglucosan accumulation in APBD fibroblasts. Guaiacol emerged as a potential candidate from this screen and improved grip strength and increased lifespan in murine APBD models. These improvements corresponded with reduced polyglucosans in peripheral nerves, liver and heart. Together, these results support further exploration of guaiacol for treating APBD.